Cardlytics Repays 2020 Convertible Senior Notes Due 2025
CDLX(NASDAQ:CDLX) ATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced the full and timely repayment of the remaining $46.1 million aggregate principal amount of its 1.00% convertible senior notes due on September 15, 2025. Following this repayment, Cardlytics now has $172.5 million aggregate principal amount outstanding of its 4.25% convertible senior notes due in 2029 and $50 million drawn on its line of credit. Cardlytics’ cash and cash equivalents as of August 31, 2025 was $92.7 million a
Cardlytics Named “Best Digital Ad Network” in 2025 MarTech Breakthrough Awards Program
CDLXATLANTA--(BUSINESS WIRE)--Cardlytics Inc. (NASDAQ: CDLX) today announced that Cardlytics’ card-linked offer (CLO) network has won “Best Digital Ad Network” in the 2025 MarTech Breakthrough Awards program conducted by MarTech Breakthrough, a market intelligence organization that recognizes today’s most innovative products, solutions, services and companies in the global field of Marketing, Sales and Ad Technology. Cardlytics’ network was recognized for its pioneering approach to card-linked offe
Cardlytics Announces Second Quarter 2025 Financial Results
CDLXATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX), a commerce media platform, today announced financial results for the second quarter ended June 30, 2025. "Building on the progress we've made over the past year, we are navigating headwinds by doubling down on our diversification efforts and reinforcing our unique network capabilities," said Amit Gupta, CEO of Cardlytics. "We believe our strategic shifts will position us for long-term profitable growth and enable us to deliver on the pr
Lake Street Maintains Hold on Cardlytics, Lowers Price Target to $2.5
CDLXCardlytics Sees Q2 Sales $61.000M-$67.000M vs $64.42M Est
CDLXCardlytics Q1 Adj. EPS $(0.21) Beats $(0.23) Estimate, Sales $61.90M Beat $58.07M Estimate
CDLXLake Street Maintains Hold on Cardlytics, Lowers Price Target to $3
CDLXEvercore ISI Group Maintains In-Line on Cardlytics, Lowers Price Target to $3
CDLXCardlytics Sees Q1 Revenue $57M-$60M Vs $61.26M Est.
CDLXCardlytics Q4 Adj. EPS $0.00 Beats $(0.18) Estimate; Sales $73.996M Beat $63.627M Estimate
CDLXNeedham Reiterates Hold on Cardlyticsto Hold
CDLXReported Saturday, Celldex Presented Barzolvolimab Data At AAAAI 2025, Highlighting Potential For Complete Disease Control In CSU And CIndU
CDLXCardlytics Sees Q4 Revenue $62M-$67M
CDLXCardlytics Q3 2024 Adj. EPS $(0.15) Beats $(0.24) Estimate, Sales $67.100M Beat $57.791M Estimate
CDLXWhat 7 Analyst Ratings Have To Say About Cardlytics
CDLXCardlytics (NASDAQ:CDLX) has observed the following analyst ratings within the last quarter:
Wells Fargo Downgrades Cardlytics to Underweight, Lowers Price Target to $13
CDLXNeedham Maintains Buy on Cardlytics, Lowers Price Target to $60
CDLXCardlytics: Q1 Earnings Insights
CDLXCardlytics (NASDAQ:CDLX) reported its Q1 earnings results on Monday, May 2, 2022 at 05:00 PM.
Here's what investors need to know about the announcement.
Earnings
Cardlytics beat estimated earnings by 30.91%, reporting an EPS of $-0.38 versus an estimate of $-0.55.
Cardlytics Sees Q2 Revenue $73M-$80M vs $74.68M Est., Billings $106M-$116M
CDLXCardlytics Q1 Adj. EPS $(0.38) Beats $(0.55) Estimate, Sales $67.90M Beat $64.66M Estimate
CDLXEarnings Outlook For Cardlytics
CDLXCardlytics (NASDAQ:CDLX) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement.
Analysts estimate that Cardlytics will report an earnings per share (EPS) of $-0.55.
